Home / People / Pavel Dřímal
Portrait ofPavel Dřimal

Pavel Dřímal

Senior Associate

Contact
CMS Cameron McKenna Nabarro Olswang, advokáti, v.o.s.
Palladium, Na Poříčí 1079/3a
110 00 Prague 1
Czech Republic
Languages Czech, Slovak, English

Pavel is a senior associate in the Commercial, Regulatory and Disputes Team at CMS Prague. He is a key member of the local life-sciences practice. 

Pavel provides advice to life-science companies on health, regulatory, compliance and corporate law issues. Pavel spent over a year on secondment with a global pharmaceutical company where he was primarily responsible for business-conduct matters in the Czech Republic and Slovakia. He also has extensive experience in drafting and negotiating general business contracts, including business conditions. He has also contributed to and led several comprehensive due diligence projects and internal investigations. Pavel advises Czech and international companies regarding their market entry into the Czech Republic. Pavel regularly provides trainings and presentations to healthcare clients on various topics, including public procurement and relationships with healthcare professionals. 

Pavel also supports various clients on meeting their on-going legal obligations in terms of filings with relevant registers, organising annual general meetings and board meetings. 

more less

Relevant experience

  • Advent International and its portfolio company Zentiva on the acquisition of the CEE assets of Alvogen. 
  • A global pharmaceutical corporation on an internal investigation related to a potential misuse of grants and donations funds and pharmaceutical as samples.
  • A global medical devices company on several criminal investigations on alleged bribery, corruption and compliance issues.
  • Various pharmaceutical companies on public procurement issues in public tenders.
  • Various pharmaceutical and MedTech companies on clinical trials, including rules on informed consent for trial subjects. 
  • A global pharmaceutical company in administrative proceedings with the Czech State Institute for Drug Control and the Czech Office for the Protection of Competition regarding their distribution model.
  • A global medical products and technologies company on pricing and reimbursement of pharmaceuticals, including negotiation of contracts with sick funds.
  • A multinational biopharmaceutical company on its liability in clinical trials of pharmaceuticals.
  • An original drug manufacturer on court disputes against various manufacturers of generic drugs.
  • A global pharmaceuticals company on court disputes with a Czech wholesaler.
     
more less

Memberships & Roles

  • Member of the Czech Bar Association
more less

Education

  • 2011 – Law Degree, Charles University, Prague 
more less

Expertise

03/09/2014
CMS advises on the sale of LBBW Bank Czech Republic
CMS has advised Landesbank Baden-Württem­berg (LBBW) on the sale of its Czech subsidiary, LBBW Bank CZ a.s., to Expobank from Russia. LBBW Bank CZ is a mid-size universal bank with 18 branches in the...
08/06/2015
CMS advises Triglav insurance group on sale of Triglav pojišťovna, a.s.
CMS Prague has advised the Slovenian insurance company Triglav INT, which is fully owned by Zavarovalnica Triglav, on the sale of its Czech subsidiary Triglav pojišťovna, a.s. to VIGO Finance, part...

Feed

27/03/2024
Cannabis law and legislation in Czech Republic
Medical use Growing cannabis for medical use is allowed upon obtaining a licence to plant cannabis plants and a permission to dispose of addictive substances and products related to medical cannabis...
18/12/2023
Digital health apps and telemedicine in Czech Republic
Digital Health Apps/Software 1. How is the software within digital health apps classified in your jurisdiction, and what regulation(s) apply? 1.1 Is it considered a “medical device” or a “product”...
Comparable
17/04/2023
CEE Expert Guide on the reimbursement of orphan drugs in Slovakia
1. Is there a legal definition of orphan drugs under your law? Yes. A reference is made to EU legislation. 2. Are orphan drugs reimbursed in your jurisdictions? Yes, either as categorised drugs or on...
Comparable
09/01/2023
Czech health ministry drafts pharmaceuticals act amendment and sets up...
Like the rest of the Europe, the Czech Republic has faced shortages of certain pharmaceuticals, including antibiotics and drugs for fever reduction for children in the final months of 2022. As a result...
15/09/2022
Pharmaceutical advertising regulation and medical device advertising in...
1. Which laws are applicable regarding advertising of medicines and medical devices? The main law applicable for advertising in general, inclusive for medicines and medical devices, is Act No. 40/1995...
07/06/2022
Adverse effects of drugs and vaccines in Czech Republic
1. Drug adverse effects: kinds of responsibility 1.1 Which are the main kinds of responsibility (contractual, in tort, criminal) of the following subjects with respect to adverse drugs reactions? A...
Comparable
02/02/2022
Changes to the Czech Public Health Insurance Act
In September 2021, the Czech Parliament adopted a long-awaited, extensive amendment to the Public Health Insurance Act (the Amendment, the Act), which became effective on 1 January 2022. The Amendment...
13/12/2021
Increase in the lawful amount of THC in hemp to 1% in the Czech Republic
The world is witnessing an increase in the popularity of hemp products, with many countries reacting by adjusting their national legislation accordingly. This particularly concerns those laws which govern...
14/09/2021
Legislative frameworks to combat illicit trade in medical products in the...
1. What legislative framework is there to combat illicit trading and other illegal activities in coun­ter­feited/fals­i­fied/di­ver­ted medicines in your jurisdiction? There are three general legislative frameworks...
Comparable
05/05/2021
Competition law and enforcement in the pharmaceuticals sector in the Czech...
1. Is there any specific regulatory framework that deals with competition regulation in the pharmaceutical sector in your country? There is no specific regulatory framework that deals exclusively with...
Comparable
22/02/2021
Czech Republic approves new rules for advertising medical devices
On 16 February 2021, the Czech president signed the new law, which amends the Advertisement Act and introduces new rules on the advertising of medical devices. As reported in our Law-Now published in...
14/09/2020
Czech Republic proposes new rules on advertising medical devices
The Czech Advertisement Act is currently undergoing some legislative changes. An amendment thereto has been included in a larger legislative package dealing with the regulation of medical devices. This...